AI-Driven CDMO Solutions for Advanced Protein Expression and Antibody Drug Development

About

A remote session on using AI to improve protein expression and antibody manufacturing at contract development and manufacturing organizations (CDMOs).

Why attend

You'll learn how AI tools are being applied to optimize production processes and reduce development timelines for protein-based therapeutics. The session covers practical applications in antibody drug development, relevant if your work involves manufacturing scale-up or process optimization.

Who

Most useful for bioprocess engineers, manufacturing scientists, and R&D leaders working in antibody or protein therapeutic development.